GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alector Inc (STU:0Z2) » Definitions » NonCurrent Deferred Liabilities

Alector (STU:0Z2) NonCurrent Deferred Liabilities : €188.21 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Alector NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Alector's non-current deferred liabilities for the quarter that ended in Mar. 2024 was €188.21 Mil.

Alector NonCurrent Deferred Liabilities Historical Data

The historical data trend for Alector's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alector NonCurrent Deferred Liabilities Chart

Alector Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial 110.91 89.12 295.96 418.54 193.35

Alector Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 402.63 226.45 215.37 193.35 188.21

Alector NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Alector's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Alector (STU:0Z2) Business Description

Industry
Traded in Other Exchanges
Address
131 Oyster Point Boulevard, Suite 600, South San Francisco, CA, USA, 94080
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Alector (STU:0Z2) Headlines

No Headlines